iBCS Paper 3: A Biopharmaceutics Classification System for Orally Inhaled Drug Products PublicationJayne HastedtDecember 7, 2023iBCS, pulmonary drug delivery
What happens when biopharmaceutics meets inhaled drug delivery? PresentationJayne HastedtDecember 7, 2022iBCS, pulmonary drug delivery
iBCS Paper 2: Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes has Published! Jayne HastedtMay 24, 2022iBCS, pulmonary drug delivery
iBCS Paper 1: Principles and Framework of an Inhalation-Based BCS has Published! PublicationJayne HastedtMay 21, 2022pulmonary drug delivery, iBCS
An overview of the iBCS presented at DDL in Edinburgh, Scotland PresentationJayne HastedtDecember 12, 2019iBCS, pulmonary drug delivery
Join us at COST Action SimInhale to discuss the iBCS and learn more about challenges and opportunities in inhalation drug delivery! PresentationJayne HastedtSeptember 30, 2019iBCS, pulmonary drug delivery
Ever had issues with moisture? PublicationJayne HastedtSeptember 20, 2019pulmonary drug delivery, amorphous
Learn about the challenges of establishing bioequivalence for orally inhaled drug products PublicationJayne HastedtApril 15, 2019pulmonary drug delivery, iBCS
The latest review of the iBCS as presented at the 4th PQRI/FDA Conference PresentationJayne HastedtApril 10, 2019iBCS, pulmonary drug delivery
Spray drying for pulmonary drug delivery PublicationJayne HastedtMarch 21, 2019amorphous, pulmonary drug delivery
